NASDAQ:INCR InterCure (INCR) Stock Price, News & Analysis → #1 election stock (From Porter & Company) (Ad) Free INCR Stock Alerts $2.96 +0.04 (+1.37%) (As of 05/1/2024 ET) Add Compare Share Share Today's Range$2.84▼$3.1350-Day Range$1.75▼$2.9652-Week Range$0.99▼$3.13Volume249,100 shsAverage Volume55,468 shsMarket Capitalization$134.89 millionP/E Ratio22.77Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get InterCure alerts: Email Address Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About InterCure Stock (NASDAQ:INCR)InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.Read More INCR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INCR Stock News HeadlinesMay 1, 2024 | businesswire.comInterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 millionApril 1, 2024 | msn.comThis Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza ConflictMay 2, 2024 | MillPub (Ad)😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.March 22, 2024 | businesswire.comInterCure Congratulates Germany on Cannabis Reform, Expanding its Global FootprintFebruary 23, 2024 | businesswire.comPESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis LandscapeFebruary 13, 2024 | finance.yahoo.comInterCure Provides an Update Regarding Nir Oz FacilityFebruary 13, 2024 | globenewswire.comInterCure Provides an Update Regarding Nir Oz FacilityJanuary 31, 2024 | msn.comInterCure to buy Isreal-based Leon cannabis pharmacy chainMay 2, 2024 | MillPub (Ad)😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.January 18, 2024 | investing.comIntrakat Technikon Kai Energeiakon Ergon AE (INCr)January 10, 2024 | msn.comWKEY, INCR and ZJYL are among pre market gainersJanuary 9, 2024 | benzinga.comIntercure Stock (NASDAQ:INCR) Dividends: History, Yield and DatesJanuary 6, 2024 | investing.comINCR_t3 Historical DataNovember 9, 2023 | morningstar.comIntercure Ltd INCROctober 17, 2023 | msn.comInterCure says one of its sites designated as closed military area by Israeli authoritiesSeptember 1, 2023 | benzinga.comCanndoc Reports Record Revenue Amid Cannabis Market TurmoilAugust 22, 2023 | theglobeandmail.comClosing Bell: Intercure Ltd up on Monday (INCR-U)August 19, 2023 | theglobeandmail.comul: Bottom 25 Performing Stocks Year-to-Date on TSX (INCR-U)August 3, 2023 | msn.comInterCure: Leader In Israel's Growing Medical Cannabis MarketJuly 23, 2023 | theglobeandmail.comIntercure: Top 10 Undervalued Micro Cap Stocks on TSX (INCR-U)July 10, 2023 | financialpost.comInterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASEMay 16, 2023 | finanznachrichten.deInterCure Ltd.: InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOYMay 16, 2023 | msn.comInterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The DetailsMay 15, 2023 | benzinga.comInterCure Announces Record Breaking First Quarter Revenues with 22% growth YOYApril 27, 2023 | theglobeandmail.comClosing Bell: Intercure Ltd down on Monday (INCR-U)April 26, 2023 | theglobeandmail.comClosing Bell: Intercure Ltd flat on Monday (INCR-U)April 25, 2023 | finance.yahoo.comInterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its SubsidiarySee More Headlines Receive INCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/01/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:INCR CUSIPN/A CIK1857030 Webwww.intercure.co Phone972774605012FaxN/AEmployees370Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio22.77 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$115.83 million Price / Sales1.16 Cash Flow$0.45 per share Price / Cash Flow6.65 Book Value$3.64 per share Price / Book0.81Miscellaneous Outstanding Shares45,570,000Free FloatN/AMarket Cap$134.89 million OptionableOptionable Beta1.73 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Alexander Rabinovich (Age 53)CEO & Director Comp: $500kMr. Amos Cohen (Age 45)Chief Financial Officer Comp: $848kEinat ZehaviVice President of SalesMr. Omri BatzirCorporate ControllerKey CompetitorsCoya TherapeuticsNASDAQ:COYAVistagen TherapeuticsNASDAQ:VTGNSagimet BiosciencesNASDAQ:SGMTI-MabNASDAQ:IMABAmylyx PharmaceuticalsNASDAQ:AMLXView All CompetitorsInstitutional OwnershipMirae Asset Global Investments Co. Ltd.Sold 467,995 shares on 5/1/2024Ownership: 1.477%Simplex Trading LLCBought 100 shares on 2/2/2024Ownership: 0.000%View All Institutional Transactions INCR Stock Analysis - Frequently Asked Questions How have INCR shares performed in 2024? InterCure's stock was trading at $1.2898 at the beginning of 2024. Since then, INCR shares have increased by 129.5% and is now trading at $2.96. View the best growth stocks for 2024 here. Are investors shorting InterCure? InterCure saw a drop in short interest in April. As of April 15th, there was short interest totaling 56,200 shares, a drop of 37.7% from the March 31st total of 90,200 shares. Based on an average daily volume of 90,200 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.2% of the shares of the company are sold short. View InterCure's Short Interest. When is InterCure's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our INCR earnings forecast. Who are InterCure's major shareholders? InterCure's stock is owned by many different institutional and retail investors. Top institutional investors include Mirae Asset Global Investments Co. Ltd. (1.48%). How do I buy shares of InterCure? Shares of INCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:INCR) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics😱 This phenomenon is smashing regular market gainsMillPubDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget Nvidia. This is the future of AIPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InterCure Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
